The global transcatheter heart valve replacement (TAVR) market is estimated to be valued at USD 8.18 billion in 2025 and is projected to reach USD 32.82 billion by 2035, registering a compound annual ...

The pharmaceutical industry stands at a breaking point. Global health challenges—from aging populations to rising chronic diseases—are pushing drug delivery systems to their limits. Yet, despite ...